phenobarbital has been researched along with Atherogenesis in 2 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SUKASOVA, MI | 1 |
| Tekgul, H | 1 |
| Demir, N | 1 |
| Gokben, S | 1 |
2 other studies available for phenobarbital and Atherogenesis
| Article | Year |
|---|---|
[Treatment of atherosclerosis with the preparation Delipin].
Topics: Arteriosclerosis; Ascorbic Acid; Atherosclerosis; Humans; Methionine; Phenobarbital; Pyridoxine | 1962 |
Serum lipid profile in children receiving anti-epileptic drug monotherapy: is it atherogenic?
Topics: Adolescent; Anticonvulsants; Apolipoproteins; Atherosclerosis; Carbamazepine; Child; Cholesterol, HD | 2006 |